pq912	be	inhibitor
we	report on	first clinical study with pq912 in subject with biomarker-proven alzheimer 's disease
aim	determine	treatment-related pharmacodynamic effect
exploratory efficacy readout	be	tailor to patient population with early ad
therapeutic approach	focus	capture by various measure
